nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—NR3C1—prostate cancer	0.0941	0.401	CbGaD
Prednisone—CYP2C19—prostate cancer	0.0858	0.366	CbGaD
Prednisone—Exemestane—Estrone—prostate cancer	0.0796	0.311	CrCrCtD
Prednisone—Exemestane—Conjugated Estrogens—prostate cancer	0.0701	0.274	CrCrCtD
Prednisone—CYP3A4—prostate cancer	0.0545	0.233	CbGaD
Prednisone—Testolactone—Estrone—prostate cancer	0.0416	0.163	CrCrCtD
Prednisone—Danazol—Ethinyl Estradiol—prostate cancer	0.0376	0.147	CrCrCtD
Prednisone—SLCO1A2—Estrone—prostate cancer	0.0305	0.101	CbGbCtD
Prednisone—Methyltestosterone—Ethinyl Estradiol—prostate cancer	0.0269	0.105	CrCrCtD
Prednisone—ALB—Abiraterone—prostate cancer	0.0218	0.0722	CbGbCtD
Prednisone—SLCO1A2—Conjugated Estrogens—prostate cancer	0.0199	0.0661	CbGbCtD
Prednisone—SLCO1A2—Estradiol—prostate cancer	0.0175	0.058	CbGbCtD
Prednisone—CYP2C19—Bicalutamide—prostate cancer	0.017	0.0565	CbGbCtD
Prednisone—CYP2C19—Nilutamide—prostate cancer	0.017	0.0565	CbGbCtD
Prednisone—ALB—Estrone—prostate cancer	0.0157	0.0522	CbGbCtD
Prednisone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0157	0.052	CbGbCtD
Prednisone—CYP2C19—Flutamide—prostate cancer	0.0141	0.0468	CbGbCtD
Prednisone—ABCB1—Estramustine—prostate cancer	0.0128	0.0424	CbGbCtD
Prednisone—ALB—Estradiol—prostate cancer	0.00904	0.03	CbGbCtD
Prednisone—ABCB1—Cabazitaxel—prostate cancer	0.00842	0.0279	CbGbCtD
Prednisone—CYP3A4—Bicalutamide—prostate cancer	0.00823	0.0273	CbGbCtD
Prednisone—ABCB1—Estrone—prostate cancer	0.00823	0.0273	CbGbCtD
Prednisone—CYP3A4—Estramustine—prostate cancer	0.00765	0.0254	CbGbCtD
Prednisone—ABCB1—Ethinyl Estradiol—prostate cancer	0.00734	0.0243	CbGbCtD
Prednisone—CYP3A4—Flutamide—prostate cancer	0.00682	0.0226	CbGbCtD
Prednisone—CYP3A4—Abiraterone—prostate cancer	0.00682	0.0226	CbGbCtD
Prednisone—CYP2C19—Estradiol—prostate cancer	0.00586	0.0194	CbGbCtD
Prednisone—ABCB1—Conjugated Estrogens—prostate cancer	0.00538	0.0179	CbGbCtD
Prednisone—CYP3A4—Cabazitaxel—prostate cancer	0.00505	0.0167	CbGbCtD
Prednisone—CYP3A4—Estrone—prostate cancer	0.00493	0.0164	CbGbCtD
Prednisone—ABCB1—Mitoxantrone—prostate cancer	0.00489	0.0162	CbGbCtD
Prednisone—ABCB1—Estradiol—prostate cancer	0.00473	0.0157	CbGbCtD
Prednisone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0044	0.0146	CbGbCtD
Prednisone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00323	0.0107	CbGbCtD
Prednisone—ABCB1—Etoposide—prostate cancer	0.00309	0.0102	CbGbCtD
Prednisone—CYP3A4—Mitoxantrone—prostate cancer	0.00293	0.00973	CbGbCtD
Prednisone—HSD11B1—prostate gland—prostate cancer	0.00285	0.129	CbGeAlD
Prednisone—CYP3A4—Estradiol—prostate cancer	0.00283	0.00939	CbGbCtD
Prednisone—ABCB1—Docetaxel—prostate cancer	0.00282	0.00937	CbGbCtD
Prednisone—HSD11B1—seminal vesicle—prostate cancer	0.00241	0.109	CbGeAlD
Prednisone—ABCB1—Doxorubicin—prostate cancer	0.00211	0.00698	CbGbCtD
Prednisone—HSD11B1—renal system—prostate cancer	0.00194	0.0881	CbGeAlD
Prednisone—CYP2C19—urine—prostate cancer	0.00192	0.0872	CbGeAlD
Prednisone—HSD11B1—urethra—prostate cancer	0.00191	0.0865	CbGeAlD
Prednisone—CYP3A4—Etoposide—prostate cancer	0.00185	0.00613	CbGbCtD
Prednisone—CYP3A4—Docetaxel—prostate cancer	0.00169	0.00561	CbGbCtD
Prednisone—NR3C1—urine—prostate cancer	0.0015	0.0682	CbGeAlD
Prednisone—CYP3A4—Doxorubicin—prostate cancer	0.00126	0.00418	CbGbCtD
Prednisone—HSD11B1—testis—prostate cancer	0.00126	0.0569	CbGeAlD
Prednisone—CYP3A4—urine—prostate cancer	0.00114	0.0515	CbGeAlD
Prednisone—HSD11B1—lymph node—prostate cancer	0.00091	0.0413	CbGeAlD
Prednisone—SLCO1A2—renal system—prostate cancer	0.000588	0.0266	CbGeAlD
Prednisone—NR3C1—prostate gland—prostate cancer	0.000539	0.0245	CbGeAlD
Prednisone—NR3C1—seminal vesicle—prostate cancer	0.000456	0.0207	CbGeAlD
Prednisone—NR3C1—epithelium—prostate cancer	0.000396	0.018	CbGeAlD
Prednisone—SLCO1A2—testis—prostate cancer	0.00038	0.0172	CbGeAlD
Prednisone—ALB—testis—prostate cancer	0.000378	0.0171	CbGeAlD
Prednisone—NR3C1—renal system—prostate cancer	0.000368	0.0167	CbGeAlD
Prednisone—NR3C1—urethra—prostate cancer	0.000361	0.0164	CbGeAlD
Prednisone—ABCB1—prostate gland—prostate cancer	0.000289	0.0131	CbGeAlD
Prednisone—CYP3A4—renal system—prostate cancer	0.000278	0.0126	CbGeAlD
Prednisone—NR3C1—bone marrow—prostate cancer	0.000278	0.0126	CbGeAlD
Prednisone—ALB—lymph node—prostate cancer	0.000274	0.0124	CbGeAlD
Prednisone—ABCB1—seminal vesicle—prostate cancer	0.000244	0.0111	CbGeAlD
Prednisone—NR3C1—testis—prostate cancer	0.000238	0.0108	CbGeAlD
Prednisone—Amcinonide—ANXA1—prostate cancer	0.000233	0.0744	CrCbGaD
Prednisone—ABCB1—epithelium—prostate cancer	0.000212	0.00962	CbGeAlD
Prednisone—ABCB1—renal system—prostate cancer	0.000197	0.00893	CbGeAlD
Prednisone—ABCB1—urethra—prostate cancer	0.000193	0.00877	CbGeAlD
Prednisone—NR3C1—lymph node—prostate cancer	0.000172	0.00781	CbGeAlD
Prednisone—ABCB1—bone marrow—prostate cancer	0.000149	0.00675	CbGeAlD
Prednisone—ABCB1—testis—prostate cancer	0.000127	0.00577	CbGeAlD
Prednisone—Hydrocortisone—ANXA1—prostate cancer	9.81e-05	0.0313	CrCbGaD
Prednisone—Exemestane—CYP19A1—prostate cancer	9.81e-05	0.0313	CrCbGaD
Prednisone—Testolactone—CYP19A1—prostate cancer	9.36e-05	0.0299	CrCbGaD
Prednisone—Dexamethasone—CYP3A43—prostate cancer	9.25e-05	0.0296	CrCbGaD
Prednisone—ABCB1—lymph node—prostate cancer	9.22e-05	0.00418	CbGeAlD
Prednisone—Prednicarbate—NR3C1—prostate cancer	7.58e-05	0.0242	CrCbGaD
Prednisone—Dexamethasone—ANXA1—prostate cancer	7.31e-05	0.0234	CrCbGaD
Prednisone—Diflorasone—NR3C1—prostate cancer	7.18e-05	0.0229	CrCbGaD
Prednisone—Desonide—NR3C1—prostate cancer	7.18e-05	0.0229	CrCbGaD
Prednisone—Desoximetasone—NR3C1—prostate cancer	7e-05	0.0224	CrCbGaD
Prednisone—Loteprednol—NR3C1—prostate cancer	6.92e-05	0.0221	CrCbGaD
Prednisone—Fludrocortisone—AR—prostate cancer	6.82e-05	0.0218	CrCbGaD
Prednisone—Danazol—SHBG—prostate cancer	6.14e-05	0.0196	CrCbGaD
Prednisone—Hydrocortamate—NR3C1—prostate cancer	5.93e-05	0.0189	CrCbGaD
Prednisone—Cortisone acetate—NR3C1—prostate cancer	5.83e-05	0.0186	CrCbGaD
Prednisone—Budesonide—NR3C1—prostate cancer	5.51e-05	0.0176	CrCbGaD
Prednisone—Amcinonide—NR3C1—prostate cancer	5.51e-05	0.0176	CrCbGaD
Prednisone—Danazol—AR—prostate cancer	5.38e-05	0.0172	CrCbGaD
Prednisone—Mometasone—NR3C1—prostate cancer	5.24e-05	0.0167	CrCbGaD
Prednisone—Methyltestosterone—SHBG—prostate cancer	5.19e-05	0.0166	CrCbGaD
Prednisone—Rimexolone—NR3C1—prostate cancer	5.18e-05	0.0166	CrCbGaD
Prednisone—Alclometasone—NR3C1—prostate cancer	4.75e-05	0.0152	CrCbGaD
Prednisone—Flunisolide—NR3C1—prostate cancer	4.62e-05	0.0148	CrCbGaD
Prednisone—Fludrocortisone—NR3C1—prostate cancer	4.62e-05	0.0148	CrCbGaD
Prednisone—Clobetasol propionate—NR3C1—prostate cancer	4.62e-05	0.0148	CrCbGaD
Prednisone—Exemestane—CYP3A4—prostate cancer	4.61e-05	0.0147	CrCbGaD
Prednisone—Paramethasone—NR3C1—prostate cancer	4.57e-05	0.0146	CrCbGaD
Prednisone—Methyltestosterone—AR—prostate cancer	4.55e-05	0.0145	CrCbGaD
Prednisone—Danazol—CYP19A1—prostate cancer	4.5e-05	0.0144	CrCbGaD
Prednisone—Ciclesonide—NR3C1—prostate cancer	4.49e-05	0.0144	CrCbGaD
Prednisone—Fluorometholone—NR3C1—prostate cancer	4.46e-05	0.0142	CrCbGaD
Prednisone—Methylprednisolone—NR3C1—prostate cancer	4.31e-05	0.0138	CrCbGaD
Prednisone—Dexamethasone—CYP17A1—prostate cancer	4.2e-05	0.0134	CrCbGaD
Prednisone—Clobetasol propionate—CYP1A1—prostate cancer	4.2e-05	0.0134	CrCbGaD
Prednisone—Danazol—ESR1—prostate cancer	4.15e-05	0.0132	CrCbGaD
Prednisone—Prednisolone—CYP2A6—prostate cancer	3.94e-05	0.0126	CrCbGaD
Prednisone—Hydrocortisone—SHBG—prostate cancer	3.91e-05	0.0125	CrCbGaD
Prednisone—Methyltestosterone—CYP19A1—prostate cancer	3.81e-05	0.0122	CrCbGaD
Prednisone—Betamethasone—CYP19A1—prostate cancer	3.67e-05	0.0117	CrCbGaD
Prednisone—Triamcinolone—NR3C1—prostate cancer	3.63e-05	0.0116	CrCbGaD
Prednisone—Hydrocortamate—CYP3A4—prostate cancer	3.44e-05	0.011	CrCbGaD
Prednisone—Cortisone acetate—CYP3A4—prostate cancer	3.38e-05	0.0108	CrCbGaD
Prednisone—Budesonide—CYP3A4—prostate cancer	3.19e-05	0.0102	CrCbGaD
Prednisone—Hydrocortisone—CYP3A5—prostate cancer	3.11e-05	0.00994	CrCbGaD
Prednisone—Prednisolone—NR3C1—prostate cancer	3.04e-05	0.0097	CrCbGaD
Prednisone—Betamethasone—NR3C1—prostate cancer	2.98e-05	0.00951	CrCbGaD
Prednisone—Dexamethasone—CYP1B1—prostate cancer	2.91e-05	0.0093	CrCbGaD
Prednisone—Alclometasone—CYP3A4—prostate cancer	2.75e-05	0.0088	CrCbGaD
Prednisone—Body temperature increased—Mitoxantrone—prostate cancer	2.72e-05	0.000253	CcSEcCtD
Prednisone—Abdominal pain—Mitoxantrone—prostate cancer	2.72e-05	0.000253	CcSEcCtD
Prednisone—Anaemia—Docetaxel—prostate cancer	2.69e-05	0.00025	CcSEcCtD
Prednisone—Flunisolide—CYP3A4—prostate cancer	2.68e-05	0.00856	CrCbGaD
Prednisone—Muscular weakness—Doxorubicin—prostate cancer	2.66e-05	0.000248	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Doxorubicin—prostate cancer	2.66e-05	0.000248	CcSEcCtD
Prednisone—Vision blurred—Capecitabine—prostate cancer	2.66e-05	0.000247	CcSEcCtD
Prednisone—Asthenia—Estradiol—prostate cancer	2.65e-05	0.000246	CcSEcCtD
Prednisone—Paramethasone—CYP3A4—prostate cancer	2.65e-05	0.00846	CrCbGaD
Prednisone—Neutropenia—Epirubicin—prostate cancer	2.64e-05	0.000245	CcSEcCtD
Prednisone—Abdominal distension—Doxorubicin—prostate cancer	2.63e-05	0.000244	CcSEcCtD
Prednisone—Ill-defined disorder—Capecitabine—prostate cancer	2.62e-05	0.000243	CcSEcCtD
Prednisone—Syncope—Docetaxel—prostate cancer	2.61e-05	0.000243	CcSEcCtD
Prednisone—Pruritus—Estradiol—prostate cancer	2.61e-05	0.000243	CcSEcCtD
Prednisone—Anaemia—Capecitabine—prostate cancer	2.61e-05	0.000242	CcSEcCtD
Prednisone—Ciclesonide—CYP3A4—prostate cancer	2.6e-05	0.00832	CrCbGaD
Prednisone—Fluorometholone—CYP3A4—prostate cancer	2.58e-05	0.00825	CrCbGaD
Prednisone—Paraesthesia—Etoposide—prostate cancer	2.57e-05	0.000239	CcSEcCtD
Prednisone—Weight increased—Epirubicin—prostate cancer	2.57e-05	0.000239	CcSEcCtD
Prednisone—Loss of consciousness—Docetaxel—prostate cancer	2.56e-05	0.000238	CcSEcCtD
Prednisone—Pancreatitis—Doxorubicin—prostate cancer	2.56e-05	0.000238	CcSEcCtD
Prednisone—Weight decreased—Epirubicin—prostate cancer	2.55e-05	0.000237	CcSEcCtD
Prednisone—Hyperglycaemia—Epirubicin—prostate cancer	2.54e-05	0.000237	CcSEcCtD
Prednisone—Malaise—Capecitabine—prostate cancer	2.54e-05	0.000236	CcSEcCtD
Prednisone—Vertigo—Capecitabine—prostate cancer	2.53e-05	0.000236	CcSEcCtD
Prednisone—Hypersensitivity—Mitoxantrone—prostate cancer	2.53e-05	0.000236	CcSEcCtD
Prednisone—Syncope—Capecitabine—prostate cancer	2.53e-05	0.000235	CcSEcCtD
Prednisone—Diarrhoea—Estradiol—prostate cancer	2.53e-05	0.000235	CcSEcCtD
Prednisone—Convulsion—Docetaxel—prostate cancer	2.52e-05	0.000235	CcSEcCtD
Prednisone—Hypertension—Docetaxel—prostate cancer	2.51e-05	0.000234	CcSEcCtD
Prednisone—Methylprednisolone—CYP3A4—prostate cancer	2.5e-05	0.00798	CrCbGaD
Prednisone—Decreased appetite—Etoposide—prostate cancer	2.49e-05	0.000231	CcSEcCtD
Prednisone—Arthralgia—Docetaxel—prostate cancer	2.48e-05	0.000231	CcSEcCtD
Prednisone—Myalgia—Docetaxel—prostate cancer	2.48e-05	0.000231	CcSEcCtD
Prednisone—Loss of consciousness—Capecitabine—prostate cancer	2.48e-05	0.00023	CcSEcCtD
Prednisone—Asthenia—Mitoxantrone—prostate cancer	2.47e-05	0.000229	CcSEcCtD
Prednisone—Fatigue—Etoposide—prostate cancer	2.47e-05	0.000229	CcSEcCtD
Prednisone—Neuropathy peripheral—Epirubicin—prostate cancer	2.46e-05	0.000229	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	2.46e-05	0.000229	CcSEcCtD
Prednisone—Constipation—Etoposide—prostate cancer	2.45e-05	0.000227	CcSEcCtD
Prednisone—Dizziness—Estradiol—prostate cancer	2.44e-05	0.000227	CcSEcCtD
Prednisone—Neutropenia—Doxorubicin—prostate cancer	2.44e-05	0.000227	CcSEcCtD
Prednisone—Hypertension—Capecitabine—prostate cancer	2.43e-05	0.000226	CcSEcCtD
Prednisone—Myalgia—Capecitabine—prostate cancer	2.4e-05	0.000223	CcSEcCtD
Prednisone—Arthralgia—Capecitabine—prostate cancer	2.4e-05	0.000223	CcSEcCtD
Prednisone—Anxiety—Capecitabine—prostate cancer	2.39e-05	0.000222	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	2.38e-05	0.000222	CcSEcCtD
Prednisone—Anaphylactic shock—Docetaxel—prostate cancer	2.38e-05	0.000221	CcSEcCtD
Prednisone—Oedema—Docetaxel—prostate cancer	2.38e-05	0.000221	CcSEcCtD
Prednisone—Weight increased—Doxorubicin—prostate cancer	2.37e-05	0.000221	CcSEcCtD
Prednisone—Discomfort—Capecitabine—prostate cancer	2.37e-05	0.000221	CcSEcCtD
Prednisone—Infection—Docetaxel—prostate cancer	2.36e-05	0.00022	CcSEcCtD
Prednisone—Weight decreased—Doxorubicin—prostate cancer	2.36e-05	0.000219	CcSEcCtD
Prednisone—Feeling abnormal—Etoposide—prostate cancer	2.36e-05	0.000219	CcSEcCtD
Prednisone—Hyperglycaemia—Doxorubicin—prostate cancer	2.35e-05	0.000219	CcSEcCtD
Prednisone—Diarrhoea—Mitoxantrone—prostate cancer	2.35e-05	0.000219	CcSEcCtD
Prednisone—Vomiting—Estradiol—prostate cancer	2.35e-05	0.000218	CcSEcCtD
Prednisone—Gastrointestinal pain—Etoposide—prostate cancer	2.34e-05	0.000217	CcSEcCtD
Prednisone—Shock—Docetaxel—prostate cancer	2.34e-05	0.000217	CcSEcCtD
Prednisone—Nervous system disorder—Docetaxel—prostate cancer	2.33e-05	0.000217	CcSEcCtD
Prednisone—Rash—Estradiol—prostate cancer	2.33e-05	0.000216	CcSEcCtD
Prednisone—Dermatitis—Estradiol—prostate cancer	2.32e-05	0.000216	CcSEcCtD
Prednisone—Hydrocortisone—NR3C1—prostate cancer	2.32e-05	0.00742	CrCbGaD
Prednisone—Tachycardia—Docetaxel—prostate cancer	2.32e-05	0.000216	CcSEcCtD
Prednisone—Dexamethasone—CYP3A5—prostate cancer	2.32e-05	0.00741	CrCbGaD
Prednisone—Headache—Estradiol—prostate cancer	2.31e-05	0.000215	CcSEcCtD
Prednisone—Skin disorder—Docetaxel—prostate cancer	2.31e-05	0.000215	CcSEcCtD
Prednisone—Oedema—Capecitabine—prostate cancer	2.3e-05	0.000214	CcSEcCtD
Prednisone—Bradycardia—Epirubicin—prostate cancer	2.3e-05	0.000214	CcSEcCtD
Prednisone—Infection—Capecitabine—prostate cancer	2.29e-05	0.000213	CcSEcCtD
Prednisone—Neuropathy peripheral—Doxorubicin—prostate cancer	2.28e-05	0.000212	CcSEcCtD
Prednisone—Urticaria—Etoposide—prostate cancer	2.27e-05	0.000211	CcSEcCtD
Prednisone—Haemoglobin—Epirubicin—prostate cancer	2.27e-05	0.000211	CcSEcCtD
Prednisone—Anorexia—Docetaxel—prostate cancer	2.27e-05	0.000211	CcSEcCtD
Prednisone—Shock—Capecitabine—prostate cancer	2.26e-05	0.000211	CcSEcCtD
Prednisone—Body temperature increased—Etoposide—prostate cancer	2.26e-05	0.00021	CcSEcCtD
Prednisone—Abdominal pain—Etoposide—prostate cancer	2.26e-05	0.00021	CcSEcCtD
Prednisone—Nervous system disorder—Capecitabine—prostate cancer	2.26e-05	0.00021	CcSEcCtD
Prednisone—Haemorrhage—Epirubicin—prostate cancer	2.26e-05	0.00021	CcSEcCtD
Prednisone—Tachycardia—Capecitabine—prostate cancer	2.25e-05	0.000209	CcSEcCtD
Prednisone—Dexamethasone—CYP2A6—prostate cancer	2.24e-05	0.00717	CrCbGaD
Prednisone—Skin disorder—Capecitabine—prostate cancer	2.24e-05	0.000208	CcSEcCtD
Prednisone—Hyperhidrosis—Capecitabine—prostate cancer	2.22e-05	0.000207	CcSEcCtD
Prednisone—Connective tissue disorder—Epirubicin—prostate cancer	2.22e-05	0.000206	CcSEcCtD
Prednisone—Anorexia—Capecitabine—prostate cancer	2.19e-05	0.000204	CcSEcCtD
Prednisone—Nausea—Estradiol—prostate cancer	2.19e-05	0.000204	CcSEcCtD
Prednisone—Vomiting—Mitoxantrone—prostate cancer	2.19e-05	0.000203	CcSEcCtD
Prednisone—Rash—Mitoxantrone—prostate cancer	2.17e-05	0.000202	CcSEcCtD
Prednisone—Dermatitis—Mitoxantrone—prostate cancer	2.17e-05	0.000201	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.17e-05	0.000201	CcSEcCtD
Prednisone—Headache—Mitoxantrone—prostate cancer	2.15e-05	0.0002	CcSEcCtD
Prednisone—Insomnia—Docetaxel—prostate cancer	2.15e-05	0.0002	CcSEcCtD
Prednisone—Dexamethasone—CYP19A1—prostate cancer	2.14e-05	0.00683	CrCbGaD
Prednisone—Paraesthesia—Docetaxel—prostate cancer	2.13e-05	0.000198	CcSEcCtD
Prednisone—Bradycardia—Doxorubicin—prostate cancer	2.13e-05	0.000198	CcSEcCtD
Prednisone—Danazol—CYP3A4—prostate cancer	2.12e-05	0.00676	CrCbGaD
Prednisone—Eye disorder—Epirubicin—prostate cancer	2.11e-05	0.000196	CcSEcCtD
Prednisone—Hypersensitivity—Etoposide—prostate cancer	2.11e-05	0.000196	CcSEcCtD
Prednisone—Triamcinolone—CYP3A4—prostate cancer	2.11e-05	0.00673	CrCbGaD
Prednisone—Haemoglobin—Doxorubicin—prostate cancer	2.1e-05	0.000195	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.1e-05	0.000195	CcSEcCtD
Prednisone—Flushing—Epirubicin—prostate cancer	2.09e-05	0.000195	CcSEcCtD
Prednisone—Dyspepsia—Docetaxel—prostate cancer	2.09e-05	0.000195	CcSEcCtD
Prednisone—Haemorrhage—Doxorubicin—prostate cancer	2.09e-05	0.000194	CcSEcCtD
Prednisone—Insomnia—Capecitabine—prostate cancer	2.08e-05	0.000194	CcSEcCtD
Prednisone—Paraesthesia—Capecitabine—prostate cancer	2.07e-05	0.000192	CcSEcCtD
Prednisone—Decreased appetite—Docetaxel—prostate cancer	2.07e-05	0.000192	CcSEcCtD
Prednisone—Triamcinolone—PTGS2—prostate cancer	2.06e-05	0.00659	CrCbGaD
Prednisone—Asthenia—Etoposide—prostate cancer	2.05e-05	0.000191	CcSEcCtD
Prednisone—Connective tissue disorder—Doxorubicin—prostate cancer	2.05e-05	0.000191	CcSEcCtD
Prednisone—Fatigue—Docetaxel—prostate cancer	2.05e-05	0.000191	CcSEcCtD
Prednisone—Angiopathy—Epirubicin—prostate cancer	2.05e-05	0.00019	CcSEcCtD
Prednisone—Nausea—Mitoxantrone—prostate cancer	2.04e-05	0.00019	CcSEcCtD
Prednisone—Immune system disorder—Epirubicin—prostate cancer	2.04e-05	0.00019	CcSEcCtD
Prednisone—Constipation—Docetaxel—prostate cancer	2.03e-05	0.000189	CcSEcCtD
Prednisone—Dyspepsia—Capecitabine—prostate cancer	2.03e-05	0.000188	CcSEcCtD
Prednisone—Pruritus—Etoposide—prostate cancer	2.02e-05	0.000188	CcSEcCtD
Prednisone—Arrhythmia—Epirubicin—prostate cancer	2.02e-05	0.000187	CcSEcCtD
Prednisone—Decreased appetite—Capecitabine—prostate cancer	2e-05	0.000186	CcSEcCtD
Prednisone—Alopecia—Epirubicin—prostate cancer	1.99e-05	0.000185	CcSEcCtD
Prednisone—Fatigue—Capecitabine—prostate cancer	1.98e-05	0.000185	CcSEcCtD
Prednisone—Mental disorder—Epirubicin—prostate cancer	1.98e-05	0.000184	CcSEcCtD
Prednisone—Constipation—Capecitabine—prostate cancer	1.97e-05	0.000183	CcSEcCtD
Prednisone—Malnutrition—Epirubicin—prostate cancer	1.96e-05	0.000183	CcSEcCtD
Prednisone—Erythema—Epirubicin—prostate cancer	1.96e-05	0.000183	CcSEcCtD
Prednisone—Feeling abnormal—Docetaxel—prostate cancer	1.96e-05	0.000182	CcSEcCtD
Prednisone—Diarrhoea—Etoposide—prostate cancer	1.96e-05	0.000182	CcSEcCtD
Prednisone—Eye disorder—Doxorubicin—prostate cancer	1.95e-05	0.000181	CcSEcCtD
Prednisone—Gastrointestinal pain—Docetaxel—prostate cancer	1.94e-05	0.000181	CcSEcCtD
Prednisone—Flushing—Doxorubicin—prostate cancer	1.94e-05	0.00018	CcSEcCtD
Prednisone—Feeling abnormal—Capecitabine—prostate cancer	1.9e-05	0.000176	CcSEcCtD
Prednisone—Angiopathy—Doxorubicin—prostate cancer	1.89e-05	0.000176	CcSEcCtD
Prednisone—Dizziness—Etoposide—prostate cancer	1.89e-05	0.000176	CcSEcCtD
Prednisone—Immune system disorder—Doxorubicin—prostate cancer	1.89e-05	0.000175	CcSEcCtD
Prednisone—Gastrointestinal pain—Capecitabine—prostate cancer	1.88e-05	0.000175	CcSEcCtD
Prednisone—Body temperature increased—Docetaxel—prostate cancer	1.88e-05	0.000175	CcSEcCtD
Prednisone—Abdominal pain—Docetaxel—prostate cancer	1.88e-05	0.000175	CcSEcCtD
Prednisone—Arrhythmia—Doxorubicin—prostate cancer	1.87e-05	0.000173	CcSEcCtD
Prednisone—Vision blurred—Epirubicin—prostate cancer	1.85e-05	0.000172	CcSEcCtD
Prednisone—Alopecia—Doxorubicin—prostate cancer	1.85e-05	0.000172	CcSEcCtD
Prednisone—Mental disorder—Doxorubicin—prostate cancer	1.83e-05	0.00017	CcSEcCtD
Prednisone—Urticaria—Capecitabine—prostate cancer	1.83e-05	0.00017	CcSEcCtD
Prednisone—Ill-defined disorder—Epirubicin—prostate cancer	1.82e-05	0.00017	CcSEcCtD
Prednisone—Body temperature increased—Capecitabine—prostate cancer	1.82e-05	0.000169	CcSEcCtD
Prednisone—Abdominal pain—Capecitabine—prostate cancer	1.82e-05	0.000169	CcSEcCtD
Prednisone—Vomiting—Etoposide—prostate cancer	1.82e-05	0.000169	CcSEcCtD
Prednisone—Erythema—Doxorubicin—prostate cancer	1.82e-05	0.000169	CcSEcCtD
Prednisone—Malnutrition—Doxorubicin—prostate cancer	1.82e-05	0.000169	CcSEcCtD
Prednisone—Anaemia—Epirubicin—prostate cancer	1.82e-05	0.000169	CcSEcCtD
Prednisone—Agitation—Epirubicin—prostate cancer	1.81e-05	0.000168	CcSEcCtD
Prednisone—Rash—Etoposide—prostate cancer	1.8e-05	0.000168	CcSEcCtD
Prednisone—Dermatitis—Etoposide—prostate cancer	1.8e-05	0.000168	CcSEcCtD
Prednisone—Headache—Etoposide—prostate cancer	1.79e-05	0.000167	CcSEcCtD
Prednisone—Methyltestosterone—CYP3A4—prostate cancer	1.79e-05	0.00571	CrCbGaD
Prednisone—Malaise—Epirubicin—prostate cancer	1.77e-05	0.000165	CcSEcCtD
Prednisone—Vertigo—Epirubicin—prostate cancer	1.77e-05	0.000164	CcSEcCtD
Prednisone—Syncope—Epirubicin—prostate cancer	1.76e-05	0.000164	CcSEcCtD
Prednisone—Prednisolone—CYP3A4—prostate cancer	1.76e-05	0.00563	CrCbGaD
Prednisone—Hypersensitivity—Docetaxel—prostate cancer	1.75e-05	0.000163	CcSEcCtD
Prednisone—Dexamethasone—NR3C1—prostate cancer	1.73e-05	0.00553	CrCbGaD
Prednisone—Loss of consciousness—Epirubicin—prostate cancer	1.73e-05	0.000161	CcSEcCtD
Prednisone—Betamethasone—CYP3A4—prostate cancer	1.72e-05	0.00551	CrCbGaD
Prednisone—Vision blurred—Doxorubicin—prostate cancer	1.71e-05	0.000159	CcSEcCtD
Prednisone—Asthenia—Docetaxel—prostate cancer	1.71e-05	0.000159	CcSEcCtD
Prednisone—Convulsion—Epirubicin—prostate cancer	1.7e-05	0.000158	CcSEcCtD
Prednisone—Nausea—Etoposide—prostate cancer	1.7e-05	0.000158	CcSEcCtD
Prednisone—Hypertension—Epirubicin—prostate cancer	1.7e-05	0.000158	CcSEcCtD
Prednisone—Hypersensitivity—Capecitabine—prostate cancer	1.7e-05	0.000158	CcSEcCtD
Prednisone—Betamethasone—PTGS2—prostate cancer	1.69e-05	0.0054	CrCbGaD
Prednisone—Ill-defined disorder—Doxorubicin—prostate cancer	1.69e-05	0.000157	CcSEcCtD
Prednisone—Pruritus—Docetaxel—prostate cancer	1.68e-05	0.000156	CcSEcCtD
Prednisone—Anaemia—Doxorubicin—prostate cancer	1.68e-05	0.000156	CcSEcCtD
Prednisone—Arthralgia—Epirubicin—prostate cancer	1.67e-05	0.000156	CcSEcCtD
Prednisone—Myalgia—Epirubicin—prostate cancer	1.67e-05	0.000156	CcSEcCtD
Prednisone—Agitation—Doxorubicin—prostate cancer	1.67e-05	0.000155	CcSEcCtD
Prednisone—Anxiety—Epirubicin—prostate cancer	1.67e-05	0.000155	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.66e-05	0.000154	CcSEcCtD
Prednisone—Discomfort—Epirubicin—prostate cancer	1.65e-05	0.000154	CcSEcCtD
Prednisone—Asthenia—Capecitabine—prostate cancer	1.65e-05	0.000154	CcSEcCtD
Prednisone—Malaise—Doxorubicin—prostate cancer	1.64e-05	0.000152	CcSEcCtD
Prednisone—Vertigo—Doxorubicin—prostate cancer	1.63e-05	0.000152	CcSEcCtD
Prednisone—Syncope—Doxorubicin—prostate cancer	1.63e-05	0.000152	CcSEcCtD
Prednisone—Pruritus—Capecitabine—prostate cancer	1.63e-05	0.000151	CcSEcCtD
Prednisone—Diarrhoea—Docetaxel—prostate cancer	1.63e-05	0.000151	CcSEcCtD
Prednisone—Oedema—Epirubicin—prostate cancer	1.6e-05	0.000149	CcSEcCtD
Prednisone—Anaphylactic shock—Epirubicin—prostate cancer	1.6e-05	0.000149	CcSEcCtD
Prednisone—Loss of consciousness—Doxorubicin—prostate cancer	1.6e-05	0.000149	CcSEcCtD
Prednisone—Dexamethasone—CYP2E1—prostate cancer	1.59e-05	0.00509	CrCbGaD
Prednisone—Infection—Epirubicin—prostate cancer	1.59e-05	0.000148	CcSEcCtD
Prednisone—Dexamethasone—CYP2C19—prostate cancer	1.58e-05	0.00504	CrCbGaD
Prednisone—Shock—Epirubicin—prostate cancer	1.58e-05	0.000147	CcSEcCtD
Prednisone—Convulsion—Doxorubicin—prostate cancer	1.57e-05	0.000146	CcSEcCtD
Prednisone—Diarrhoea—Capecitabine—prostate cancer	1.57e-05	0.000146	CcSEcCtD
Prednisone—Nervous system disorder—Epirubicin—prostate cancer	1.57e-05	0.000146	CcSEcCtD
Prednisone—Dizziness—Docetaxel—prostate cancer	1.57e-05	0.000146	CcSEcCtD
Prednisone—Dexamethasone—CYP1A1—prostate cancer	1.57e-05	0.00502	CrCbGaD
Prednisone—Hypertension—Doxorubicin—prostate cancer	1.57e-05	0.000146	CcSEcCtD
Prednisone—Tachycardia—Epirubicin—prostate cancer	1.56e-05	0.000146	CcSEcCtD
Prednisone—Skin disorder—Epirubicin—prostate cancer	1.56e-05	0.000145	CcSEcCtD
Prednisone—Hyperhidrosis—Epirubicin—prostate cancer	1.55e-05	0.000144	CcSEcCtD
Prednisone—Arthralgia—Doxorubicin—prostate cancer	1.55e-05	0.000144	CcSEcCtD
Prednisone—Myalgia—Doxorubicin—prostate cancer	1.55e-05	0.000144	CcSEcCtD
Prednisone—Anxiety—Doxorubicin—prostate cancer	1.54e-05	0.000143	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.54e-05	0.000143	CcSEcCtD
Prednisone—Discomfort—Doxorubicin—prostate cancer	1.53e-05	0.000142	CcSEcCtD
Prednisone—Anorexia—Epirubicin—prostate cancer	1.53e-05	0.000142	CcSEcCtD
Prednisone—Dizziness—Capecitabine—prostate cancer	1.52e-05	0.000142	CcSEcCtD
Prednisone—Vomiting—Docetaxel—prostate cancer	1.51e-05	0.000141	CcSEcCtD
Prednisone—Rash—Docetaxel—prostate cancer	1.5e-05	0.000139	CcSEcCtD
Prednisone—Dermatitis—Docetaxel—prostate cancer	1.5e-05	0.000139	CcSEcCtD
Prednisone—Headache—Docetaxel—prostate cancer	1.49e-05	0.000138	CcSEcCtD
Prednisone—Anaphylactic shock—Doxorubicin—prostate cancer	1.48e-05	0.000138	CcSEcCtD
Prednisone—Oedema—Doxorubicin—prostate cancer	1.48e-05	0.000138	CcSEcCtD
Prednisone—Infection—Doxorubicin—prostate cancer	1.47e-05	0.000137	CcSEcCtD
Prednisone—Vomiting—Capecitabine—prostate cancer	1.46e-05	0.000136	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.46e-05	0.000136	CcSEcCtD
Prednisone—Shock—Doxorubicin—prostate cancer	1.46e-05	0.000136	CcSEcCtD
Prednisone—Nervous system disorder—Doxorubicin—prostate cancer	1.45e-05	0.000135	CcSEcCtD
Prednisone—Rash—Capecitabine—prostate cancer	1.45e-05	0.000135	CcSEcCtD
Prednisone—Insomnia—Epirubicin—prostate cancer	1.45e-05	0.000135	CcSEcCtD
Prednisone—Dermatitis—Capecitabine—prostate cancer	1.45e-05	0.000135	CcSEcCtD
Prednisone—Tachycardia—Doxorubicin—prostate cancer	1.45e-05	0.000135	CcSEcCtD
Prednisone—Headache—Capecitabine—prostate cancer	1.44e-05	0.000134	CcSEcCtD
Prednisone—Skin disorder—Doxorubicin—prostate cancer	1.44e-05	0.000134	CcSEcCtD
Prednisone—Paraesthesia—Epirubicin—prostate cancer	1.44e-05	0.000134	CcSEcCtD
Prednisone—Hyperhidrosis—Doxorubicin—prostate cancer	1.43e-05	0.000133	CcSEcCtD
Prednisone—Anorexia—Doxorubicin—prostate cancer	1.41e-05	0.000132	CcSEcCtD
Prednisone—Nausea—Docetaxel—prostate cancer	1.41e-05	0.000131	CcSEcCtD
Prednisone—Dyspepsia—Epirubicin—prostate cancer	1.41e-05	0.000131	CcSEcCtD
Prednisone—Decreased appetite—Epirubicin—prostate cancer	1.39e-05	0.00013	CcSEcCtD
Prednisone—Fatigue—Epirubicin—prostate cancer	1.38e-05	0.000129	CcSEcCtD
Prednisone—Constipation—Epirubicin—prostate cancer	1.37e-05	0.000127	CcSEcCtD
Prednisone—Nausea—Capecitabine—prostate cancer	1.37e-05	0.000127	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.35e-05	0.000126	CcSEcCtD
Prednisone—Hydrocortisone—CYP3A4—prostate cancer	1.35e-05	0.0043	CrCbGaD
Prednisone—Insomnia—Doxorubicin—prostate cancer	1.34e-05	0.000125	CcSEcCtD
Prednisone—Paraesthesia—Doxorubicin—prostate cancer	1.33e-05	0.000124	CcSEcCtD
Prednisone—Feeling abnormal—Epirubicin—prostate cancer	1.32e-05	0.000123	CcSEcCtD
Prednisone—Gastrointestinal pain—Epirubicin—prostate cancer	1.31e-05	0.000122	CcSEcCtD
Prednisone—Dyspepsia—Doxorubicin—prostate cancer	1.31e-05	0.000121	CcSEcCtD
Prednisone—Decreased appetite—Doxorubicin—prostate cancer	1.29e-05	0.00012	CcSEcCtD
Prednisone—Fatigue—Doxorubicin—prostate cancer	1.28e-05	0.000119	CcSEcCtD
Prednisone—Urticaria—Epirubicin—prostate cancer	1.27e-05	0.000118	CcSEcCtD
Prednisone—Constipation—Doxorubicin—prostate cancer	1.27e-05	0.000118	CcSEcCtD
Prednisone—Body temperature increased—Epirubicin—prostate cancer	1.27e-05	0.000118	CcSEcCtD
Prednisone—Abdominal pain—Epirubicin—prostate cancer	1.27e-05	0.000118	CcSEcCtD
Prednisone—Feeling abnormal—Doxorubicin—prostate cancer	1.22e-05	0.000114	CcSEcCtD
Prednisone—Gastrointestinal pain—Doxorubicin—prostate cancer	1.21e-05	0.000113	CcSEcCtD
Prednisone—Hypersensitivity—Epirubicin—prostate cancer	1.18e-05	0.00011	CcSEcCtD
Prednisone—Urticaria—Doxorubicin—prostate cancer	1.18e-05	0.00011	CcSEcCtD
Prednisone—Body temperature increased—Doxorubicin—prostate cancer	1.17e-05	0.000109	CcSEcCtD
Prednisone—Abdominal pain—Doxorubicin—prostate cancer	1.17e-05	0.000109	CcSEcCtD
Prednisone—Asthenia—Epirubicin—prostate cancer	1.15e-05	0.000107	CcSEcCtD
Prednisone—Pruritus—Epirubicin—prostate cancer	1.13e-05	0.000105	CcSEcCtD
Prednisone—Diarrhoea—Epirubicin—prostate cancer	1.1e-05	0.000102	CcSEcCtD
Prednisone—Hypersensitivity—Doxorubicin—prostate cancer	1.09e-05	0.000102	CcSEcCtD
Prednisone—Asthenia—Doxorubicin—prostate cancer	1.06e-05	9.9e-05	CcSEcCtD
Prednisone—Dizziness—Epirubicin—prostate cancer	1.06e-05	9.86e-05	CcSEcCtD
Prednisone—Pruritus—Doxorubicin—prostate cancer	1.05e-05	9.76e-05	CcSEcCtD
Prednisone—Vomiting—Epirubicin—prostate cancer	1.02e-05	9.48e-05	CcSEcCtD
Prednisone—Diarrhoea—Doxorubicin—prostate cancer	1.02e-05	9.44e-05	CcSEcCtD
Prednisone—Rash—Epirubicin—prostate cancer	1.01e-05	9.4e-05	CcSEcCtD
Prednisone—Dermatitis—Epirubicin—prostate cancer	1.01e-05	9.39e-05	CcSEcCtD
Prednisone—Headache—Epirubicin—prostate cancer	1e-05	9.34e-05	CcSEcCtD
Prednisone—Dexamethasone—CYP3A4—prostate cancer	1e-05	0.00321	CrCbGaD
Prednisone—Dexamethasone—PTGS2—prostate cancer	9.82e-06	0.00314	CrCbGaD
Prednisone—Dizziness—Doxorubicin—prostate cancer	9.81e-06	9.12e-05	CcSEcCtD
Prednisone—Nausea—Epirubicin—prostate cancer	9.52e-06	8.86e-05	CcSEcCtD
Prednisone—Vomiting—Doxorubicin—prostate cancer	9.43e-06	8.77e-05	CcSEcCtD
Prednisone—Rash—Doxorubicin—prostate cancer	9.35e-06	8.7e-05	CcSEcCtD
Prednisone—Dermatitis—Doxorubicin—prostate cancer	9.35e-06	8.69e-05	CcSEcCtD
Prednisone—Headache—Doxorubicin—prostate cancer	9.29e-06	8.64e-05	CcSEcCtD
Prednisone—Nausea—Doxorubicin—prostate cancer	8.81e-06	8.19e-05	CcSEcCtD
Prednisone—CYP2C19—Metabolism—MED12—prostate cancer	2.86e-06	3.79e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SERPINE1—prostate cancer	2.86e-06	3.79e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SULT2A1—prostate cancer	2.84e-06	3.76e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GNG5—prostate cancer	2.84e-06	3.76e-05	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	2.84e-06	3.76e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—ACHE—prostate cancer	2.82e-06	3.73e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTT1—prostate cancer	2.82e-06	3.73e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—MED12—prostate cancer	2.79e-06	3.7e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP2A6—prostate cancer	2.78e-06	3.69e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP7B1—prostate cancer	2.78e-06	3.69e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—MTAP—prostate cancer	2.78e-06	3.69e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.77e-06	3.67e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GNG5—prostate cancer	2.77e-06	3.67e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NCOA3—prostate cancer	2.73e-06	3.62e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—NOS3—prostate cancer	2.73e-06	3.61e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CG—prostate cancer	2.73e-06	3.61e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SULT1E1—prostate cancer	2.71e-06	3.59e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SRD5A1—prostate cancer	2.71e-06	3.59e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—AKR1C3—prostate cancer	2.71e-06	3.59e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PRKACB—prostate cancer	2.69e-06	3.57e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.68e-06	3.56e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NCOA3—prostate cancer	2.67e-06	3.53e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP17A1—prostate cancer	2.67e-06	3.53e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—JAK2—prostate cancer	2.65e-06	3.51e-05	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.64e-06	3.49e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.63e-06	3.48e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—HPGDS—prostate cancer	2.61e-06	3.45e-05	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—CREBBP—prostate cancer	2.59e-06	3.43e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—HSD17B3—prostate cancer	2.59e-06	3.43e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ACSL4—prostate cancer	2.59e-06	3.43e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—INS—prostate cancer	2.58e-06	3.42e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—HPGDS—prostate cancer	2.54e-06	3.37e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—NCOA2—prostate cancer	2.54e-06	3.37e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP2C19—prostate cancer	2.53e-06	3.35e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ACHE—prostate cancer	2.53e-06	3.35e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTT1—prostate cancer	2.53e-06	3.35e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CREBBP—prostate cancer	2.53e-06	3.35e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CB—prostate cancer	2.52e-06	3.34e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP2A6—prostate cancer	2.5e-06	3.31e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.49e-06	3.3e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ARG2—prostate cancer	2.48e-06	3.29e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—UMPS—prostate cancer	2.48e-06	3.29e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PHGDH—prostate cancer	2.48e-06	3.29e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTT1—prostate cancer	2.47e-06	3.27e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ACHE—prostate cancer	2.47e-06	3.27e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP2A6—prostate cancer	2.44e-06	3.23e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—LDHB—prostate cancer	2.43e-06	3.22e-05	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	2.43e-06	3.22e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AKR1C3—prostate cancer	2.43e-06	3.22e-05	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—SERPINE1—prostate cancer	2.43e-06	3.22e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—SLC5A5—prostate cancer	2.42e-06	3.21e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PRKACB—prostate cancer	2.42e-06	3.2e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CD—prostate cancer	2.4e-06	3.18e-05	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	2.39e-06	3.17e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP17A1—prostate cancer	2.39e-06	3.17e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP3A5—prostate cancer	2.39e-06	3.16e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AKR1C3—prostate cancer	2.37e-06	3.14e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP2E1—prostate cancer	2.37e-06	3.14e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.36e-06	3.13e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PRKACB—prostate cancer	2.36e-06	3.13e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—NQO1—prostate cancer	2.34e-06	3.1e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP17A1—prostate cancer	2.34e-06	3.1e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IL2—prostate cancer	2.31e-06	3.06e-05	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.31e-06	3.06e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—TH—prostate cancer	2.31e-06	3.06e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—TCN2—prostate cancer	2.31e-06	3.06e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—UCP3—prostate cancer	2.31e-06	3.06e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTA3—prostate cancer	2.31e-06	3.06e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PDHA1—prostate cancer	2.31e-06	3.06e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.29e-06	3.04e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP3A4—prostate cancer	2.28e-06	3.02e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NCOA2—prostate cancer	2.28e-06	3.02e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.27e-06	3.01e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—NOS3—prostate cancer	2.26e-06	3e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP1B1—prostate cancer	2.24e-06	2.97e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NCOA2—prostate cancer	2.23e-06	2.95e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.2e-06	2.91e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.2e-06	2.91e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SLC5A5—prostate cancer	2.17e-06	2.88e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—GGT1—prostate cancer	2.17e-06	2.88e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—NCOA1—prostate cancer	2.14e-06	2.84e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP2E1—prostate cancer	2.12e-06	2.82e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SLC5A5—prostate cancer	2.12e-06	2.81e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP19A1—prostate cancer	2.11e-06	2.8e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTA4—prostate cancer	2.11e-06	2.79e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.11e-06	2.79e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NQO1—prostate cancer	2.1e-06	2.78e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CB—prostate cancer	2.09e-06	2.77e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—EP300—prostate cancer	2.07e-06	2.75e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP2E1—prostate cancer	2.07e-06	2.75e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—TH—prostate cancer	2.07e-06	2.74e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTGS2—prostate cancer	2.07e-06	2.74e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.06e-06	2.73e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTA2—prostate cancer	2.05e-06	2.72e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NQO1—prostate cancer	2.05e-06	2.72e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP3A4—prostate cancer	2.05e-06	2.72e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.04e-06	2.7e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—RXRA—prostate cancer	2.04e-06	2.7e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.03e-06	2.69e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ABCG5—prostate cancer	2.03e-06	2.69e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—TH—prostate cancer	2.02e-06	2.68e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SRC—prostate cancer	2.02e-06	2.67e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP1B1—prostate cancer	2.01e-06	2.67e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP3A4—prostate cancer	2e-06	2.65e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTA1—prostate cancer	1.98e-06	2.63e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.98e-06	2.62e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP1B1—prostate cancer	1.97e-06	2.61e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—VEGFA—prostate cancer	1.96e-06	2.6e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—COMT—prostate cancer	1.96e-06	2.6e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTO1—prostate cancer	1.96e-06	2.6e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.96e-06	2.6e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NAT2—prostate cancer	1.96e-06	2.6e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTP1—prostate cancer	1.95e-06	2.59e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GGT1—prostate cancer	1.95e-06	2.59e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NCOA1—prostate cancer	1.92e-06	2.55e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—ITPR1—prostate cancer	1.92e-06	2.55e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GGT1—prostate cancer	1.9e-06	2.52e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP19A1—prostate cancer	1.89e-06	2.51e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.89e-06	2.5e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—LRP2—prostate cancer	1.88e-06	2.49e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PLCB2—prostate cancer	1.88e-06	2.49e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.88e-06	2.49e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NCOA1—prostate cancer	1.88e-06	2.49e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP19A1—prostate cancer	1.85e-06	2.45e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—P4HB—prostate cancer	1.84e-06	2.44e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—RXRA—prostate cancer	1.83e-06	2.42e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—TYMS—prostate cancer	1.81e-06	2.4e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTEN—prostate cancer	1.8e-06	2.39e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TGFB1—prostate cancer	1.8e-06	2.39e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTM1—prostate cancer	1.79e-06	2.38e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.79e-06	2.38e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—RXRA—prostate cancer	1.78e-06	2.36e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.78e-06	2.36e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—LPL—prostate cancer	1.76e-06	2.33e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—COMT—prostate cancer	1.76e-06	2.33e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTP1—prostate cancer	1.75e-06	2.32e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.75e-06	2.32e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ITPR1—prostate cancer	1.72e-06	2.28e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—EP300—prostate cancer	1.72e-06	2.28e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—MED12—prostate cancer	1.72e-06	2.28e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—COMT—prostate cancer	1.72e-06	2.28e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTP1—prostate cancer	1.71e-06	2.27e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GNG5—prostate cancer	1.71e-06	2.26e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP1A1—prostate cancer	1.7e-06	2.25e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.69e-06	2.25e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—ERCC2—prostate cancer	1.69e-06	2.23e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ITPR1—prostate cancer	1.68e-06	2.23e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—KRAS—prostate cancer	1.67e-06	2.21e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NCOA3—prostate cancer	1.64e-06	2.18e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—TYMS—prostate cancer	1.63e-06	2.16e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTM1—prostate cancer	1.61e-06	2.13e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—TYMS—prostate cancer	1.59e-06	2.11e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—MTHFR—prostate cancer	1.58e-06	2.1e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—LPL—prostate cancer	1.58e-06	2.09e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTM1—prostate cancer	1.57e-06	2.08e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—HPGDS—prostate cancer	1.57e-06	2.08e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.56e-06	2.06e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PPARA—prostate cancer	1.55e-06	2.06e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—LPL—prostate cancer	1.54e-06	2.04e-05	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MYC—prostate cancer	1.54e-06	2.04e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CA—prostate cancer	1.53e-06	2.03e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.53e-06	2.02e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ACHE—prostate cancer	1.52e-06	2.01e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTT1—prostate cancer	1.52e-06	2.01e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ERCC2—prostate cancer	1.51e-06	2.01e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.5e-06	1.99e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP1A1—prostate cancer	1.49e-06	1.97e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—prostate cancer	1.48e-06	1.97e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ERCC2—prostate cancer	1.48e-06	1.96e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—CAV1—prostate cancer	1.46e-06	1.94e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.46e-06	1.94e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PRKACB—prostate cancer	1.45e-06	1.93e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.44e-06	1.91e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—MTHFR—prostate cancer	1.42e-06	1.89e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.4e-06	1.85e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PPARA—prostate cancer	1.4e-06	1.85e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—MTHFR—prostate cancer	1.39e-06	1.84e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NCOA2—prostate cancer	1.37e-06	1.82e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PPARA—prostate cancer	1.36e-06	1.81e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CG—prostate cancer	1.33e-06	1.77e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CAV1—prostate cancer	1.31e-06	1.74e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.31e-06	1.73e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CAV1—prostate cancer	1.28e-06	1.7e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.28e-06	1.69e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CA—prostate cancer	1.27e-06	1.69e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NQO1—prostate cancer	1.26e-06	1.67e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—INS—prostate cancer	1.26e-06	1.67e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.25e-06	1.66e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—AKT1—prostate cancer	1.25e-06	1.66e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—TH—prostate cancer	1.24e-06	1.65e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—CREBBP—prostate cancer	1.23e-06	1.64e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.21e-06	1.61e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.2e-06	1.58e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GGT1—prostate cancer	1.17e-06	1.55e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CD—prostate cancer	1.17e-06	1.55e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CG—prostate cancer	1.17e-06	1.55e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NCOA1—prostate cancer	1.16e-06	1.53e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.14e-06	1.51e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—INS—prostate cancer	1.13e-06	1.5e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CREBBP—prostate cancer	1.11e-06	1.47e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—NOS3—prostate cancer	1.11e-06	1.47e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—INS—prostate cancer	1.1e-06	1.46e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—RXRA—prostate cancer	1.1e-06	1.46e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CREBBP—prostate cancer	1.08e-06	1.43e-05	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—AKT1—prostate cancer	1.07e-06	1.41e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—COMT—prostate cancer	1.06e-06	1.4e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTP1—prostate cancer	1.05e-06	1.4e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.05e-06	1.39e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—AKT1—prostate cancer	1.04e-06	1.38e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ITPR1—prostate cancer	1.04e-06	1.37e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CD—prostate cancer	1.03e-06	1.36e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CB—prostate cancer	1.02e-06	1.35e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTGS2—prostate cancer	1.01e-06	1.34e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NOS3—prostate cancer	9.92e-07	1.32e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—TYMS—prostate cancer	9.79e-07	1.3e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NOS3—prostate cancer	9.69e-07	1.28e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTM1—prostate cancer	9.68e-07	1.28e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—LPL—prostate cancer	9.5e-07	1.26e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP1A1—prostate cancer	9.18e-07	1.22e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CB—prostate cancer	9.16e-07	1.21e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ERCC2—prostate cancer	9.1e-07	1.21e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTGS2—prostate cancer	9.08e-07	1.2e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CB—prostate cancer	8.94e-07	1.19e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTGS2—prostate cancer	8.86e-07	1.17e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTEN—prostate cancer	8.82e-07	1.17e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—MTHFR—prostate cancer	8.56e-07	1.13e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—EP300—prostate cancer	8.41e-07	1.11e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PPARA—prostate cancer	8.39e-07	1.11e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTEN—prostate cancer	7.92e-07	1.05e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CAV1—prostate cancer	7.89e-07	1.05e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTEN—prostate cancer	7.73e-07	1.02e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—EP300—prostate cancer	7.55e-07	1e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—EP300—prostate cancer	7.37e-07	9.77e-06	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CG—prostate cancer	7.19e-07	9.53e-06	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—INS—prostate cancer	6.8e-07	9.02e-06	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CREBBP—prostate cancer	6.66e-07	8.83e-06	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CD—prostate cancer	6.32e-07	8.38e-06	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CA—prostate cancer	6.22e-07	8.24e-06	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NOS3—prostate cancer	5.97e-07	7.91e-06	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CA—prostate cancer	5.58e-07	7.4e-06	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.51e-07	7.3e-06	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTGS2—prostate cancer	5.46e-07	7.23e-06	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CA—prostate cancer	5.45e-07	7.22e-06	CbGpPWpGaD
Prednisone—ALB—Metabolism—AKT1—prostate cancer	5.08e-07	6.74e-06	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTEN—prostate cancer	4.76e-07	6.31e-06	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AKT1—prostate cancer	4.56e-07	6.05e-06	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—EP300—prostate cancer	4.54e-07	6.02e-06	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AKT1—prostate cancer	4.45e-07	5.9e-06	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.36e-07	4.45e-06	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AKT1—prostate cancer	2.74e-07	3.64e-06	CbGpPWpGaD
